The Korean Journal of Pain

The Korean Pain Society (대한통증학회)
권호 표지
DOI QR코드

DOI QR Code

Etiopathogenesis of sacroiliitis: implications for assessment and management

  • Baronio, Manuela (Dipartimento di Anestesia, Rianimazione, Terapia Intensiva e del Dolore, Fondazione Poliambulanza) ;
  • Sadia, Hajra (Atta-ur-Rahman School of Applied Biosciences, National University of Science and Technology) ;
  • Paolacci, Stefano (MAGI's Lab) ;
  • Prestamburgo, Domenico (Ortopedia e Traumatologia, Ospedali Civili di Legnano e Cuggiono) ;
  • Miotti, Danilo (Cure Palliative e Terapia del Dolore, ICS Maugeri) ;
  • Guardamagna, Vittorio A. (Cure Palliative e Terapia del Dolore, IRCCS IEO) ;
  • Natalini, Giuseppe (Dipartimento di Anestesia, Rianimazione, Terapia Intensiva e del Dolore, Fondazione Poliambulanza) ;
  • Bertelli, Matteo (MAGI's Lab)
  • Received : 2020.01.16
  • Accepted : 2020.04.16
  • Published : 2020.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

The sacroiliac joints connect the base of the sacrum to the ilium. When inflamed, they are suspected to cause low back pain. Inflammation of the sacroiliac joints is called sacroiliitis. The severity of the pain varies and depends on the degree of inflammation. Sacroiliitis is a hallmark of seronegative spondyloarthropathies. The presence or absence of chronic sacroiliitis is an important clue in the diagnosis of low back pain. This article aims to provide a concise overview of the anatomy, physiology, and molecular biology of sacroiliitis to aid clinicians in the assessment and management of sacroiliitis. For this narrative review, we evaluated articles in English published before August 2019 in PubMed. Then, we selected articles related to the painful manifestations of the sacroiliac joint. From the retrieved articles, we found that chronic sacroiliitis may be caused by various forms of spondyloarthritis, such as ankylosing spondyloarthritis. Sacroiliitis can also be associated with inflammatory bowel disease, Crohn's disease, gout, tuberculosis, brucellosis, and osteoarthritis, indicating common underlying etiological factors. The pathophysiology of sacroiliitis is complex and may involve internal, environmental, immunological, and genetic factors. Finally, genetic factors may also play a central role in progression of the disease. Knowing the genetic pre-disposition for sacroiliitis can be useful for diagnosis and for formulating treatment regimens, and may lead to a substantial reduction in disease severity and duration and to improved patient performance.

Keywords

References

  1. Buchanan BK, Varacallo M. Sacroiliitis [Internet]. Treasure Island (FL): StatPearls Publishing; 2020. Available at: http://www.ncbi.nlm.nih.gov/books/NBK448141/.
  2. Rashbaum RF, Ohnmeiss DD, Lindley EM, Kitchel SH, Patel VV. Sacroiliac joint pain and its treatment. Clin Spine Surg 2016; 29: 42-8. https://doi.org/10.1097/BSD.0000000000000359
  3. Dietrichs E. Anatomy of the pelvic joints--a review. Scand J Rheumatol Suppl 1991; 88: 4-6.
  4. Prather H, Hunt D. Conservative management of low back pain, part I. Sacroiliac joint pain. Dis Mon 2004; 50: 670-83. https://doi.org/10.1016/j.disamonth.2004.12.004
  5. Solonen KA. The sacroiliac joint in the light of anatomical, roentgenological and clinical studies. Acta Orthop Scand Suppl 1957; 27: 1-127.
  6. McKenzie-Brown AM, Shah RV, Sehgal N, Everett CR. A systematic review of sacroiliac joint interventions. Pain Physician 2005; 8: 115-25.
  7. Scholten PJ, Schultz AB, Luchies CW, Miller JA. Motions and loads within the human pelvis: a biomechanical model study. J Orthop Res 1988; 6: 840-50. https://doi.org/10.1002/jor.1100060608
  8. Harrison DE, Harrison DD, Troyanovich SJ. The sacroiliac joint: a review of anatomy and biomechanics with clinical implications. J Manipulative Physiol Ther 1997; 20: 607-17.
  9. Vleeming A, Schuenke MD, Masi AT, Carreiro JE, Danneels L, Willard FH. The sacroiliac joint: an overview of its anatomy, function and potential clinical implications. J Anat 2012; 221: 537-67. https://doi.org/10.1111/j.1469-7580.2012.01564.x
  10. Vleeming A, Pool-Goudzwaard AL, Hammudoghlu D, Stoeckart R, Snijders CJ, Mens JM. The function of the long dorsal sacroiliac ligament: its implication for understanding low back pain. Spine (Phila Pa 1976) 1996; 21: 556-62. https://doi.org/10.1097/00007632-199603010-00005
  11. Wong M, Sinkler M, Kiel J. Anatomy, abdomen and pelvis, sacroiliac joint [Internet]. Treasure Island (FL): StatPearls Publishing; 2020. Available at: http://www.ncbi.nlm.nih.gov/books/NBK507801/.
  12. Becker I, Woodley SJ, Stringer MD. The adult human pubic symphysis: a systematic review. J Anat 2010; 217: 475-87. https://doi.org/10.1111/j.1469-7580.2010.01300.x
  13. Vilensky JA, O'Connor BL, Fortin JD, Merkel GJ, Jimenez AM, Scofield BA, et al. Histologic analysis of neural elements in the human sacroiliac joint. Spine (Phila Pa 1976) 2002; 27: 1202-7. https://doi.org/10.1097/00007632-200206010-00012
  14. Cunningham DJ, Romanes GJ. Cunningham's textbook of anatomy. 12th ed. Oxford, Oxford University Press. 1981, pp 691-2.
  15. Forst SL, Wheeler MT, Fortin JD, Vilensky JA. The sacroiliac joint: anatomy, physiology and clinical significance. Pain Physician 2006; 9: 61-7.
  16. Holm S, Indahl A, Solomonow M. Sensorimotor control of the spine. J Electromyogr Kinesiol 2002; 12: 219-34. https://doi.org/10.1016/S1050-6411(02)00028-7
  17. Patel N, Gross A, Brown L, Gekht G. A randomized, placebocontrolled study to assess the efficacy of lateral branch neurotomy for chronic sacroiliac joint pain. Pain Med 2012; 13: 383-98. https://doi.org/10.1111/j.1526-4637.2012.01328.x
  18. Alderink GJ. The sacroiliac joint: review of anatomy, mechanics, and function. J Orthop Sports Phys Ther 1991; 13: 71-84. https://doi.org/10.2519/jospt.1991.13.2.71
  19. Kampen WU, Tillmann B. Age-related changes in the articular cartilage of human sacroiliac joint. Anat Embryol (Berl) 1998; 198: 505-13. https://doi.org/10.1007/s004290050200
  20. Rawlings CE 3rd, Wilkins RH, Martinez S, Wilkinson RH Jr. Osteoporotic sacral fractures: a clinical study. Neurosurgery 1988; 22(1 Pt 1): 72-6. https://doi.org/10.1227/00006123-198801010-00011
  21. Prassopoulos PK, Faflia CP, Voloudaki AE, Gourtsoyiannis NC. Sacroiliac joints: anatomical variants on CT. J Comput Assist Tomogr 1999; 23: 323-7. https://doi.org/10.1097/00004728-199903000-00029
  22. Andersson GB. Epidemiological features of chronic low-back pain. Lancet 1999; 354: 581-5. https://doi.org/10.1016/S0140-6736(99)01312-4
  23. Bernard TN, Cassidy JD. The sacroiliac joint syndrome: pathophysiology, diagnosis and management. In: The adult spine: principles and practice. Edited by Frymoyer J. New York, Raven Press. 1991, pp 2107-30.
  24. Verrills P, Vivian D. Interventions in chronic low back pain. Aust Fam Physician 2004; 33: 421-6.
  25. Dreyfuss P, Dryer S, Griffin J, Hoffman J, Walsh N. Positive sacroiliac screening tests in asymptomatic adults. Spine (Phila Pa 1976) 1994; 19: 1138-43. https://doi.org/10.1097/00007632-199405001-00007
  26. Hill JA, Lombardo SJ. Ankylosing spondylitis presenting as shoulder pain in an athlete. A case report. Am J Sports Med 1981; 9: 262-4. https://doi.org/10.1177/036354658100900416
  27. Kok HK, Mumtaz A, O'Brien C, Kane D, Torreggiani WC, Delaney H. Imaging the patient with sacroiliac pain. Can Assoc Radiol J 2016; 67: 41-51. https://doi.org/10.1016/j.carj.2015.08.001
  28. Ramlakan RJ, Govender S. Sacroiliac joint tuberculosis. Int Orthop 2007; 31: 121-4. https://doi.org/10.1007/s00264-006-0132-9
  29. Hanly JG, Mitchell MJ, Barnes DC, MacMillan L. Early recognition of sacroiliitis by magnetic resonance imaging and single photon emission computed tomography. J Rheumatol 1994; 21: 2088-95.
  30. Bakker P, Molto A, Etcheto A, Van den Bosch F, Landewe R, van Gaalen F, et al. The performance of different classification criteria sets for spondyloarthritis in the worldwide ASAS-COMOSPA study. Arthritis Res Ther 2017; 19: 96. https://doi.org/10.1186/s13075-017-1281-5
  31. Rudwaleit M, Jurik AG, Hermann KG, Landewe R, van der Heijde D, Baraliakos X, et al. Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI group. Ann Rheum Dis 2009; 68: 1520-7. https://doi.org/10.1136/ard.2009.110767
  32. Tarantino A, Jablonska JP, D'Aprile P. All that glitters is not gold: sacroiliitis. Reumatologia 2018; 56: 289-93. https://doi.org/10.5114/reum.2018.79499
  33. Zelle BA, Gruen GS, Brown S, George S. Sacroiliac joint dysfunction: evaluation and management. Clin J Pain 2005; 21: 446-55. https://doi.org/10.1097/01.ajp.0000131413.07468.8e
  34. Cusi M, Saunders J, Van der Wall H, Fogelman I. Metabolic disturbances identified by SPECT-CT in patients with a clinical diagnosis of sacroiliac joint incompetence. Eur Spine J 2013; 22: 1674-82. https://doi.org/10.1007/s00586-013-2725-5
  35. Klang E, Lidar M, Lidar Z, Aharoni D, Eshed I. Prevalence and awareness of sacroiliac joint alterations on lumbar spine CT in low back pain patients younger than 40 years. Acta Radiol 2017; 58: 449-55. https://doi.org/10.1177/0284185116656490
  36. Song R, Lee S, Lee SH. Progressive sacroiliitis due to accessory sacroiliac joint mimicking ankylosing spondylitis: a case report. Medicine (Baltimore) 2019; 98: e15324. https://doi.org/10.1097/md.0000000000015324
  37. Toussirot E, Aubry S, Runge M. Unilateral accessory sacroiliac joint with bone marrow edema mimicking sacroiliitis. J Rheumatol 2018; 45: 1327-8. https://doi.org/10.3899/jrheum.180030
  38. Chou LH, Slipman CW, Bhagia SM, Tsaur L, Bhat AL, Isaac Z, et al. Inciting events initiating injection-proven sacroiliac joint syndrome. Pain Med 2004; 5: 26-32. https://doi.org/10.1111/j.1526-4637.2004.04009.x
  39. Itz CJ, Willems PC, Zeilstra DJ, Huygen FJ. Dutch multidisciplinary guideline for invasive treatment of pain syndromes of the lumbosacral spine. Pain Pract 2016; 16: 90-110. https://doi.org/10.1111/papr.12318
  40. Prather H. Sacroiliac joint pain: practical management. Clin J Sport Med 2003; 13: 252-5. https://doi.org/10.1097/00042752-200307000-00010
  41. Timm KE. Sacroiliac joint dysfunction in elite rowers. J Orthop Sports Phys Ther 1999; 29: 288-93. https://doi.org/10.2519/jospt.1999.29.5.288
  42. Lindsay DM, Meeuwisse WH, Vyse A, Mooney ME, Summersides J. Lumbosacral dysfunctions in elite cross-country skiers. J Orthop Sports Phys Ther 1993; 18: 580-5. https://doi.org/10.2519/jospt.1993.18.5.580
  43. Hill JJ, Keating JL. A systematic review of the incidence and prevalence of low back pain in children. Phys Ther Rev 2009; 14: 272-84. https://doi.org/10.1179/108331909X12488667116899
  44. Sarcevic Z, Tepavcevic A. Association between adolescent idiopathic scoliosis and sacroiliac joint dysfunction in young athletes: a case control study. Medicine (Baltimore) 2019; 98: e15161. https://doi.org/10.1097/md.0000000000015161
  45. Miller TL, Cass N, Siegel C. Ankylosing spondylitis in an athlete with chronic sacroiliac joint pain. Orthopedics 2014; 37: e207-10. https://doi.org/10.3928/01477447-20140124-27
  46. Polsunas PJ, Sowa G, Fritz JM, Gentili A, Morone NE, Raja SN, et al. Deconstructing chronic low back pain in the older adult-step by step evidence and expert-based recommendations for evaluation and treatment: part X: sacroiliac joint syndrome. Pain Med 2016; 17: 1638-47. https://doi.org/10.1093/pm/pnw151
  47. Chakrabortty S, Kumar S, Gupta D, Rudraraju S. Intractable sacroiliac joint pain treated with peripheral nerve field stimulation. J Anaesthesiol Clin Pharmacol 2016; 32: 392-4. https://doi.org/10.4103/0970-9185.173336
  48. Cairns KD, McRoberts WP, Deer T. Peripheral nerve stimulation for the treatment of truncal pain. Prog Neurol Surg 2011; 24: 58-69. https://doi.org/10.1159/000323025
  49. Shim JH, Jeon WJ, Cho SY, Yeom JH, Shin WJ, Kim KH. Sacroiliac joint injection in patients with low back pain or buttock pain: short-term follow-up results. Korean J Pain 2003; 16: 175-80.
  50. Simopoulos TT, Manchikanti L, Gupta S, Aydin SM, Kim CH, Solanki D, et al. Systematic review of the diagnostic accuracy and therapeutic effectiveness of sacroiliac joint interventions. Pain Physician 2015; 18: E713-56.
  51. Scholten PM, Patel SI, Christos PJ, Singh JR. Short-term efficacy of sacroiliac joint corticosteroid injection based on arthrographic contrast patterns. PMR 2015; 7: 385-91.
  52. Mayo Foundation for Medical Education and Research. Sacroiliitis [Internet]. Rochester (MN): Mayo Foundation for Medical Education and Research; 2018. Available at: https://www.mayoclinic.org/diseases-conditions/sacroiliitis/diagnosis-treatment/drc-20350751.
  53. Manchikanti L, Abdi S, Atluri S, Benyamin RM, Boswell MV, Buenaventura RM, et al. An update of comprehensive evidence-based guidelines for interventional techniques in chronic spinal pain. Part II: guidance and recommendations. Pain Physician 2013; 16(2 Suppl): S49-283.
  54. Sachs D, Capobianco R. Minimally invasive sacroiliac joint fusion: one-year outcomes in 40 patients. Adv Orthop 2013; 2013: 536128. https://doi.org/10.1155/2013/536128
  55. Sachs D, Kovalsky D, Redmond A, Limoni R, Meyer SC, Harvey C, et al. Durable intermediate-to long-term outcomes after minimally invasive transiliac sacroiliac joint fusion using triangular titanium implants. Med Devices (Auckl) 2016; 9: 213-22.
  56. Rudolf L, Capobianco R. Five-year clinical and radiographic outcomes after minimally invasive sacroiliac joint fusion using triangular implants. Open Orthop J 2014; 8: 375-83. https://doi.org/10.2174/1874325001408010375
  57. Vanaclocha V, Herrera JM, Saiz-Sapena N, Rivera-Paz M, Verdu-Lopez F. Minimally invasive sacroiliac joint fusion, radiofrequency denervation, and conservative management for sacroiliac joint pain: 6-year comparative case series. Neurosurgery 2018; 82: 48-55. https://doi.org/10.1093/neuros/nyx185
  58. Brown CR, Reiner SL. Genes outside the major histocompatibility complex control resistance and susceptibility to experimental Lyme arthritis. Med Microbiol Immunol 2000; 189: 85-90. https://doi.org/10.1007/s004300000044
  59. Schlosstein L, Terasaki PI, Bluestone R, Pearson CM. High association of an HL-A antigen, W27, with ankylosing spondylitis. N Engl J Med 1973; 288: 704-6. https://doi.org/10.1056/NEJM197304052881403
  60. Brewerton DA, Hart FD, Nicholls A, Caffrey M, James DC, Sturrock RD. Ankylosing spondylitis and HL-A 27. Lancet 1973; 1: 904-7.
  61. Orchard TR, Holt H, Bradbury L, Hammersma J, McNally E, Jewell DP, et al. The prevalence, clinical features and association of HLA-B27 in sacroiliitis associated with established Crohn's disease. Aliment Pharmacol Ther 2009; 29: 193-7. https://doi.org/10.1111/j.1365-2036.2008.03868.x
  62. Alkan S, Kayiran N, Zengin O, Kalem A, Kimyon G, Kilinc EO, et al. Isotretinoin-induced spondyloarthropathy-related symptoms: a prospective study. J Rheumatol 2015; 42: 2106-9. https://doi.org/10.3899/jrheum.150013
  63. Faustini F, Zoli A, Ferraccioli GF. Immunologic and genetic links between spondylarthropathies and inf lammatory bowel diseases. Eur Rev Med Pharmacol Sci 2009; 13 Suppl 1: 1-9.
  64. Eksioglu E, Oztekin F, Unlu E, Cakci A, Keyik B, Karadavut IK. Sacroiliitis and polyneuropathy during isotretinoin treatment. Clin Exp Dermatol 2008; 33: 122-4. https://doi.org/10.1111/j.1365-2230.2007.02532.x
  65. Kasifoglu T, Calisir C, Cansu DU, Korkmaz C. The frequency of sacroiliitis in familial Mediterranean fever and the role of HLA-B27 and MEFV mutations in the development of sacroiliitis. Clin Rheumatol 2009; 28: 41-6. https://doi.org/10.1007/s10067-008-0980-3
  66. van de Loo FA, Joosten LA, van Lent PL, Arntz OJ, van den Berg WB. Role of interleukin-1, tumor necrosis factor alpha, and interleukin-6 in cartilage proteoglycan metabolism and destruction. Effect of in situ blocking in murine antigen- and zymosan-induced arthritis. Arthritis Rheum 1995; 38: 164-72. https://doi.org/10.1002/art.1780380204
  67. Dale M, Nicklin MJ. Interleukin-1 receptor cluster: gene organization of IL1R2, IL1R1, IL1RL2 (IL-1Rrp2), IL1RL1 (T1/ST2), and IL18R1 (IL-1Rrp) on human chromosome 2q. Genomics 1999; 57: 177-9. https://doi.org/10.1006/geno.1999.5767
  68. Colotta F, Re F, Muzio M, Bertini R, Polentarutti N, Sironi M, et al. Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science 1993; 261: 472-5. https://doi.org/10.1126/science.8332913
  69. Jiang Y, Genant HK, Watt I, Cobby M, Bresnihan B, Aitchison R, et al. A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: radiologic progression and correlation of Genant and Larsen scores. Arthritis Rheum 2000; 43: 1001-9. https://doi.org/10.1002/1529-0131(200005)43:5<1001::AID-ANR7>3.0.CO;2-P
  70. McGarry F, Neilly J, Anderson N, Sturrock R, Field M. A polymorphism within the interleukin 1 receptor antagonist (IL- 1Ra) gene is associated with ankylosing spondylitis. Rheumatology (Oxford) 2001; 40: 1359-64. https://doi.org/10.1093/rheumatology/40.12.1359
  71. Zhang P, Li Q, Qi J, Lv Q, Zheng X, Wu X, et al. Association between vitamin D receptor gene polymorphism and ankylosing spondylitis in Han Chinese. Int J Rheum Dis 2017; 20: 1510-6. https://doi.org/10.1111/1756-185X.12949
  72. Davidson SI, Jiang L, Cortes A, Wu X, Glazov EA, Donskoi M, et al. Brief report: high-throughput sequencing of IL23R reveals a low-frequency, nonsynonymous single-nucleotide polymorphism that is associated with ankylosing spondylitis in a Han Chinese population. Arthritis Rheum 2013; 65: 1747-52. https://doi.org/10.1002/art.37976
  73. Burton PR, Clayton DG, Cardon LR, Craddock N, Deloukas P, Duncanson A, et al. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet 2007; 39: 1329-37. https://doi.org/10.1038/ng.2007.17
  74. Wellcome Trust Case Control Consortium, Australo-Anglo- American Spondylitis Consortium (TASC). A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006; 314: 1461-3. https://doi.org/10.1126/science.1135245
  75. Nair RP, Duffin KC, Helms C, Ding J, Stuart PE, Goldgar D, et al. Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat Genet 2009; 41: 199-204. https://doi.org/10.1038/ng.311
  76. Kadi A, Costantino F, Izac B, Leboime A, Said-Nahal R, Garchon HJ, et al. Brief report: the IL23R nonsynonymous polymorphism rs11209026 is associated with radiographic sacroiliitis in spondyloarthritis. Arthritis Rheum 2013; 65: 2655-60. https://doi.org/10.1002/art.38060
  77. Gorman JD, Sack KE, Davis JC Jr. Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha. N Engl J Med 2002; 346: 1349-56. https://doi.org/10.1056/NEJMoa012664
  78. Braun J, Brandt J, Listing J, Zink A, Alten R, Golder W, et al. Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial. Lancet 2002; 359: 1187-93. https://doi.org/10.1016/S0140-6736(02)08215-6
  79. Redlich K, Gortz B, Hayer S, Zwerina J, Kollias G, Steiner G, et al. Overexpression of tumor necrosis factor causes bilateral sacroiliitis. Arthritis Rheum 2004; 50: 1001-5. https://doi.org/10.1002/art.20194
  80. Peeters H, Vander Cruyssen B, Laukens D, Coucke P, Marichal D, Van Den Berghe M, et al. Radiological sacroiliitis, a hallmark of spondylitis, is linked with CARD15 gene polymorphisms in patients with Crohn's disease. Ann Rheum Dis 2004; 63: 1131-4. https://doi.org/10.1136/ard.2004.021774
  81. Peeters H, Vander Cruyssen B, Mielants H, de Vlam K, Vermeire S, Louis E, et al. Clinical and genetic factors associated with sacroiliitis in Crohn's disease. J Gastroenterol Hepatol 2008; 23: 132-7. https://doi.org/10.1111/j.1440-1746.2007.05108.x
  82. Wright C, Sibani S, Trudgian D, Fischer R, Kessler B, LaBaer J, et al. Detection of multiple autoantibodies in patients with ankylosing spondylitis using nucleic acid programmable protein arrays. Mol Cell Proteomics 2012; 11: M9.00384.
  83. Zolnierowicz S. Type 2A protein phosphatase, the complex regulator of numerous signaling pathways. Biochem Pharmacol 2000; 60: 1225-35. https://doi.org/10.1016/S0006-2952(00)00424-X
  84. Duan X, Liang YY, Feng XH, Lin X. Protein serine/threonine phosphatase PPM1A dephosphorylates Smad1 in the bone morphogenetic protein signaling pathway. J Biol Chem 2006; 281: 36526-32. https://doi.org/10.1074/jbc.M605169200
  85. Kim YG, Sohn DH, Zhao X, Sokolove J, Lindstrom TM, Yoo B, et al. Role of protein phosphatase magnesium-dependent 1A and anti-protein phosphatase magnesium-dependent 1A autoantibodies in ankylosing spondylitis. Arthritis Rheumatol 2014; 66: 2793-803. https://doi.org/10.1002/art.38763
  86. Singh Sangha M, Wright ML, Ciurtin C. Strongly positive anti-CCP antibodies in patients with sacroiliitis or reactive arthritis post-E. coli infection: a mini case-series based review. Int J Rheum Dis 2018; 21: 315-21. https://doi.org/10.1111/1756-185X.13113
  87. Prajzlerova K, Grobelna K, Husakova M, Forejtova S, Jungel A, Gay S, et al. Association between circulating miRNAs and spinal involvement in patients with axial spondyloarthritis. PLoS One 2017; 12: e0185323. https://doi.org/10.1371/journal.pone.0185323
  88. Huang J, Song G, Yin Z, Luo X, Ye Z. Elevated miR-29a expression is not correlated with disease activity index in PBMCs of patients with ankylosing spondylitis. Mod Rheumatol 2014; 24: 331-4. https://doi.org/10.3109/14397595.2013.854077
  89. Li X, Lv Q, Tu L, Zhao M, Zhang P, Li Q, et al. Aberrant expression of microRNAs in peripheral blood mononuclear cells as candidate biomarkers in patients with axial spondyloarthritis. Int J Rheum Dis 2019; 22: 1188-95. https://doi.org/10.1111/1756-185x.13563
  90. Mielants H, Veys EM, Cuvelier C, De Vos M, Goemaere S, De Clercq L, et al. The evolution of spondyloarthropathies in relation to gut histology. II. Histological aspects. J Rheumatol 1995; 22: 2273-8.
  91. Alonso Farto JC, Arias IA, Lopez Longo FJ, Gonzalez Fernandez CM, Monteagudo Saez I, Ortega Valle A, et al. Clinical significance of abdominal scintigraphy using 99mTc- HMPAO-labelled leucocytes in patients with seronegative spondyloarthropathies. Eur J Nucl Med 2000; 27: 1768-73. https://doi.org/10.1007/s002590000393
  92. Fox JG, Dewhirst FE, Fraser GJ, Paster BJ, Shames B, Murphy JC. Intracellular Campylobacter-like organism from ferrets and hamsters with proliferative bowel disease is a Desulfovibrio sp. J Clin Microbiol 1994; 32: 1229-37. https://doi.org/10.1128/jcm.32.5.1229-1237.1994
  93. Hannu T. Reactive arthritis. Best Pract Res Clin Rheumatol 2011; 25: 347-57. https://doi.org/10.1016/j.berh.2011.01.018
  94. Schiellerup P, Krogfelt KA, Locht H. A comparison of selfreported joint symptoms following infection with different enteric pathogens: effect of HLA-B27. J Rheumatol 2008; 35: 480-7.
  95. Putterman C, Rubinow A. Reactive arthritis associated with Clostridium difficile pseudomembranous colitis. Semin Arthritis Rheum 1993; 22: 420-6. https://doi.org/10.1016/S0049-0172(05)80033-2
  96. Stoll ML, Weiss PF, Weiss JE, Nigrovic PA, Edelheit BS, Bridges SL Jr, et al. Age and fecal microbial strain-specific differences in patients with spondyloarthritis. Arthritis Res Ther 2018; 20: 14. https://doi.org/10.1186/s13075-018-1510-6
  97. Ebringer A. The cross-tolerance hypothesis, HLA-B27 and ankylosing spondylitis. Br J Rheumatol 1983; 22(4 Suppl 2): 53-66. https://doi.org/10.1093/rheumatology/XXII.suppl_2.53
  98. Rath HC, Wilson KH, Sartor RB. Differential induction of colitis and gastritis in HLA-B27 transgenic rats selectively colonized with Bacteroides vulgatus or Escherichia coli. Infect Immun 1999; 67: 2969-74. https://doi.org/10.1128/iai.67.6.2969-2974.1999
  99. Baeten D, De Keyser F, Mielants H, Veys EM. Immune linkages between inflammatory bowel disease and spondyloarthropathies. Curr Opin Rheumatol 2002; 14: 342-7. https://doi.org/10.1097/00002281-200207000-00002